Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hézard

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Thrombosis and Haemostasis|November 19, 1997
Detection of factor V Leiden using ASO (allele specific oligonucleotide)N Hézard, P Cornillet, A Vallade, et al.
Journal Des Maladies Vasculaires|June 3, 1998
[Modulators of leukocytic functions]P Nguyen, M Broussas, N Hézard, et al.
Journal Des Maladies Vasculaires|December 3, 1999
[Measurement of monocyte activation: perspectives in clinical application in the investigation of the diabetic patient]P Nguyên, M Broussas, E Bertin, et al.
Journal Des Maladies Vasculaires|December 3, 1999
[Platelet activation in cardiology: methods, indications and therapeutic perspectives]N Hézard, D Metz, G Simon, et al.
Thrombosis and Haemostasis|April 20, 2001
Unexpected flow cytometric results with two small GPIIb/IIIa blockers: eptifibatide and tirofibanN Hézard, D Metz, S Tassan-Mangina, et al.
Thrombosis and Haemostasis|June 3, 1998
Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G-->A 20210 prothrombin gene and C-->T 677 MTHFR gene mutationsN Hézard, P Cornillet-Lefebvre, L Gillot, et al.
Thrombosis Research|October 23, 1997
Factor V Leiden: detection in whole blood by ASA PCR using an additional mismatch in antepenultimate positionN Hézard, P Cornillet, C Droullé, et al.
Journal Des Maladies Vasculaires|January 10, 2001
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation]N Hézard, D Metz, R Garnotel, et al.
Thrombosis and Haemostasis|April 26, 2000
Use of the PFA-100 apparatus to assess platelet function in patients undergoing PTCA during and after infusion of c7E3 Fab in the presence of other antiplatelet agentsN Hézard, D Metz, P Nazeyrollas, et al.
Journal Des Maladies Vasculaires|January 9, 2009
[Resistance to platelet antiaggregants: the cardiologist's point of view]D Metz, N Hézard, S Duval, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Thrombosis and Haemostasis|November 19, 1997
Detection of factor V Leiden using ASO (allele specific oligonucleotide)N Hézard, P Cornillet, A Vallade, et al.
Journal Des Maladies Vasculaires|June 3, 1998
[Modulators of leukocytic functions]P Nguyen, M Broussas, N Hézard, et al.
Journal Des Maladies Vasculaires|December 3, 1999
[Measurement of monocyte activation: perspectives in clinical application in the investigation of the diabetic patient]P Nguyên, M Broussas, E Bertin, et al.
Journal Des Maladies Vasculaires|December 3, 1999
[Platelet activation in cardiology: methods, indications and therapeutic perspectives]N Hézard, D Metz, G Simon, et al.
Thrombosis and Haemostasis|April 20, 2001
Unexpected flow cytometric results with two small GPIIb/IIIa blockers: eptifibatide and tirofibanN Hézard, D Metz, S Tassan-Mangina, et al.
Thrombosis and Haemostasis|June 3, 1998
Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G-->A 20210 prothrombin gene and C-->T 677 MTHFR gene mutationsN Hézard, P Cornillet-Lefebvre, L Gillot, et al.
Thrombosis Research|October 23, 1997
Factor V Leiden: detection in whole blood by ASA PCR using an additional mismatch in antepenultimate positionN Hézard, P Cornillet, C Droullé, et al.
Journal Des Maladies Vasculaires|January 10, 2001
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation]N Hézard, D Metz, R Garnotel, et al.
Thrombosis and Haemostasis|April 26, 2000
Use of the PFA-100 apparatus to assess platelet function in patients undergoing PTCA during and after infusion of c7E3 Fab in the presence of other antiplatelet agentsN Hézard, D Metz, P Nazeyrollas, et al.
Journal Des Maladies Vasculaires|January 9, 2009
[Resistance to platelet antiaggregants: the cardiologist's point of view]D Metz, N Hézard, S Duval, et al.
Pageof 2